Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Chronic diseases, inflammation, and spices: how are they linked?

Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, Bharti AC, Aggarwal BB.

J Transl Med. 2018 Jan 25;16(1):14. doi: 10.1186/s12967-018-1381-2. Review.

2.

Therapeutic startegies for human papillomavirus infection and associated cancers.

Bharti AC, Singh T, Bhat A, Pande D, Jadli M.

Front Biosci (Elite Ed). 2018 Jan 1;10:15-73.

PMID:
28930604
3.

miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis.

Shishodia G, Verma G, Das BC, Bharti AC.

Front Biosci (Schol Ed). 2018 Jan 1;10:21-47. Review.

PMID:
28930517
4.

Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity.

Tyagi A, Vishnoi K, Kaur H, Srivastava Y, Roy BG, Das BC, Bharti AC.

Sci Rep. 2017 Jul 6;7(1):4781. doi: 10.1038/s41598-017-05162-x.

5.

Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.

Verma G, Vishnoi K, Tyagi A, Jadli M, Singh T, Goel A, Sharma A, Agarwal K, Prasad SC, Pandey D, Sharma S, Mehrotra R, Singh SM, Bharti AC.

Cancer Med. 2017 Mar;6(3):591-604. doi: 10.1002/cam4.983. Epub 2017 Feb 3.

6.

Cross-talk between Human Papillomavirus Oncoproteins and Hedgehog Signaling Synergistically Promotes Stemness in Cervical Cancer Cells.

Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, Singh T, Singh SM, Bharti AC.

Sci Rep. 2016 Sep 28;6:34377. doi: 10.1038/srep34377.

7.

Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.

Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, Singh T, Singh SM, Bharti AC.

Tumour Biol. 2016 Oct;37(10):13137-13154. Epub 2016 Jul 24.

PMID:
27449048
8.

Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.

Tyagi A, Vishnoi K, Mahata S, Verma G, Srivastava Y, Masaldan S, Roy BG, Bharti AC, Das BC.

Clin Cancer Res. 2016 Aug 15;22(16):4170-84. doi: 10.1158/1078-0432.CCR-15-2574. Epub 2016 Mar 17.

9.

Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.

Gupta S, Kumar P, Kaur H, Sharma N, Saluja D, Bharti AC, Das BC.

Sci Rep. 2015 Nov 19;5:16811. doi: 10.1038/srep16811.

10.

Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil.

Pandey A, Vishnoi K, Mahata S, Tripathi SC, Misra SP, Misra V, Mehrotra R, Dwivedi M, Bharti AC.

Nutr Cancer. 2015;67(8):1293-304. doi: 10.1080/01635581.2015.1085581. Epub 2015 Oct 22.

PMID:
26492225
11.

Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.

Shishodia G, Shukla S, Srivastava Y, Masaldan S, Mehta S, Bhambhani S, Sharma S, Mehrotra R, Das BC, Bharti AC.

Mol Cancer. 2015 Jun 9;14:116. doi: 10.1186/s12943-015-0385-2.

12.

Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach.

Joshi S, Kulkarni V, Darak T, Mahajan U, Srivastava Y, Gupta S, Krishnan S, Mandolkar M, Bharti AC.

Int J Womens Health. 2015 May 4;7:477-83. doi: 10.2147/IJWH.S80624. eCollection 2015.

13.

Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.

Sharma K, Kathait A, Jain A, Kujur K, Raghuwanshi S, Bharti AC, Saklani AC, Das BC.

PLoS One. 2015 May 8;10(5):e0125693. doi: 10.1371/journal.pone.0125693. eCollection 2015.

14.

Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer.

Mishra A, Kumar R, Tyagi A, Kohaar I, Hedau S, Bharti AC, Sarker S, Dey D, Saluja D, Das B.

Ecancermedicalscience. 2015 Apr 23;9:525. doi: 10.3332/ecancer.2015.525. eCollection 2015.

15.

Folic Acid and Trastuzumab Functionalized Redox Responsive Polymersomes for Intracellular Doxorubicin Delivery in Breast Cancer.

Lale SV, Kumar A, Prasad S, Bharti AC, Koul V.

Biomacromolecules. 2015 Jun 8;16(6):1736-52. doi: 10.1021/acs.biomac.5b00244. Epub 2015 May 15.

PMID:
25918899
16.

Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.

Hedau S, Batra M, Singh UR, Bharti AC, Ray A, Das BC.

J Cancer Res Ther. 2015 Jan-Mar;11(1):158-63. doi: 10.4103/0973-1482.140985.

17.

Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.

Shishodia G, Verma G, Srivastava Y, Mehrotra R, Das BC, Bharti AC.

BMC Cancer. 2014 Dec 23;14:996. doi: 10.1186/1471-2407-14-996.

18.

Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing.

Pandey A, Tripathi SC, Mahata S, Vishnoi K, Shukla S, Misra SP, Misra V, Hedau S, Mehrotra R, Dwivedi M, Bharti AC.

World J Gastroenterol. 2014 Jun 14;20(22):6860-8. doi: 10.3748/wjg.v20.i22.6860.

19.

Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.

Shukla S, Mahata S, Shishodia G, Pande S, Verma G, Hedau S, Bhambhani S, Kumari A, Batra S, Basir SF, Das BC, Bharti AC.

Indian J Med Res. 2014 Apr;139(4):531-43.

20.

Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a phase II randomized controlled study.

Basu P, Dutta S, Begum R, Mittal S, Dutta PD, Bharti AC, Panda CK, Biswas J, Dey B, Talwar GP, Das BC.

Asian Pac J Cancer Prev. 2013;14(10):5753-9.

21.

Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.

Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K, Basir SF, Das BC, Bharti AC.

PLoS One. 2013 Jul 18;8(7):e67849. doi: 10.1371/journal.pone.0067849. Print 2013.

22.

Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells.

Mahata S, Pandey A, Shukla S, Tyagi A, Husain SA, Das BC, Bharti AC.

Nutr Cancer. 2013;65 Suppl 1:88-97. doi: 10.1080/01635581.2013.785008.

PMID:
23682787
23.

Preparation and in vitro evaluation of folate-receptor-targeted SPION-polymer micelle hybrids for MRI contrast enhancement in cancer imaging.

Mahajan S, Koul V, Choudhary V, Shishodia G, Bharti AC.

Nanotechnology. 2013 Jan 11;24(1):015603. doi: 10.1088/0957-4484/24/1/015603. Epub 2012 Dec 7.

PMID:
23221062
24.

Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages.

Vishvakarma NK, Kumar A, Kumar A, Kant S, Bharti AC, Singh SM.

Toxicol Appl Pharmacol. 2012 Aug 15;263(1):111-21. doi: 10.1016/j.taap.2012.06.004. Epub 2012 Jun 17.

PMID:
22714040
25.
26.

Effect of aspirin administration on reversal of tumor-induced suppression of myelopoiesis in T-cell lymphoma bearing host.

Kumar A, Bharti AC, Singh SM.

Blood Cells Mol Dis. 2012 Apr 15;48(4):238-46. doi: 10.1016/j.bcmd.2012.02.006. Epub 2012 Mar 14.

PMID:
22421408
27.

Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells.

Mahata S, Maru S, Shukla S, Pandey A, Mugesh G, Das BC, Bharti AC.

BMC Complement Altern Med. 2012 Mar 10;12:15. doi: 10.1186/1472-6882-12-15.

28.

Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host.

Kumar A, Vishvakarma NK, Bharti AC, Singh SM.

Blood Cells Mol Dis. 2012 Feb 15;48(2):137-44. doi: 10.1016/j.bcmd.2011.10.006. Epub 2011 Nov 21.

PMID:
22104368
29.

Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.

Sobti RC, Singh N, Hussain S, Suri V, Nijhawan R, Bharti AC, Bharadwaj M, Das BC.

Cell Oncol (Dordr). 2011 Dec;34(6):533-43. doi: 10.1007/s13402-011-0056-2. Epub 2011 Sep 21.

PMID:
21935712
30.

Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.

Kumar A, Vishvakarma NK, Tyagi A, Bharti AC, Singh SM.

Biosci Rep. 2012 Feb;32(1):91-104. doi: 10.1042/BSR20110027.

PMID:
21692746
31.

Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.

Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC.

Mol Cancer. 2011 Apr 15;10:39. doi: 10.1186/1476-4598-10-39.

32.

Efficacy of plasma TGF-β1 level in predicting therapeutic efficacy and prognosis in patients with advanced non-small cell lung cancer.

Kumar S, Guleria R, Mohan A, Singh V, Bharti AC, Das BC.

Cancer Invest. 2011 Mar;29(3):202-7. doi: 10.3109/07357907.2010.543208. Epub 2011 Jan 31.

PMID:
21280981
33.

Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women.

Hedau S, Kumar U, Hussain S, Shukla S, Pande S, Jain N, Tyagi A, Deshpande T, Bhat D, Mir MM, Chakraborty S, Singh YM, Kumar R, Somasundaram K, Bharti AC, Das BC.

BMC Cancer. 2011 Jan 20;11:27. doi: 10.1186/1471-2407-11-27.

34.

Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.

Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, Bhambhani S, Batra S, Basir SF, Das BC, Bharti AC.

Mol Cancer. 2010 Oct 27;9:282. doi: 10.1186/1476-4598-9-282.

35.
36.

Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.

Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M.

Biomarkers. 2010 Dec;15(8):684-92. doi: 10.3109/1354750X.2010.511267. Epub 2010 Sep 23.

PMID:
20860530
37.

Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18.

Shukla S, Bharti AC, Mahata S, Hussain S, Hedau S, Sharma R, Pillai MR, Krishna S, Chiplunkar S, Tongaonkar H, Das BC.

J Med Microbiol. 2010 Nov;59(Pt 11):1303-10. doi: 10.1099/jmm.0.019240-0. Epub 2010 Aug 5.

PMID:
20688948
38.

Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.

Chaudhary AK, Singh M, Bharti AC, Singh M, Shukla S, Singh AK, Mehrotra R.

BMC Cancer. 2010 Jul 14;10:369. doi: 10.1186/1471-2407-10-369.

39.

Lack of utility of plasma TNF-alpha level in predicting therapeutic efficacy in patients with advanced non-small cell lung cancer.

Kumar S, Guleria R, Singh V, Mohan A, Bharti AC, Das BC.

Cytokine. 2010 Sep;51(3):245-8. doi: 10.1016/j.cyto.2010.05.007.

PMID:
20599393
40.

Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis.

Bharti AC, Panigrahi A, Sharma PK, Gupta N, Kumar R, Shukla S, Bhowmik DM, Agarwal SK, Guleria S, Mehra NK.

Exp Clin Transplant. 2010 Jun;8(2):161-71.

41.

Utility of plasma tumour necrosis factor-alpha and transforming growth factor-beta1 as predictors of survival and treatment outcome in advanced non-small cell lung carcinoma.

Kumar S, Guleria R, Mohan A, Singh V, Ali A, Bharti AC, Das BC.

Biomarkers. 2010 Aug;15(5):446-53. doi: 10.3109/1354750X.2010.485699.

PMID:
20486867
42.

Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer.

Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC.

Eur Respir J. 2010 Oct;36(4):885-92. doi: 10.1183/09031936.00187909. Epub 2010 Feb 25.

43.

Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy.

Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC.

Lung Cancer. 2010 Nov;70(2):211-7. doi: 10.1016/j.lungcan.2010.01.021. Epub 2010 Feb 23.

PMID:
20181407
44.

Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R.

J Biomed Sci. 2010 Feb 15;17:10. doi: 10.1186/1423-0127-17-10. Review.

45.

Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer.

Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC.

Clin Lung Cancer. 2010 Jan;11(1):36-44. doi: 10.3816/CLC.2010.n.006.

PMID:
20085866
46.

Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer.

Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC.

BMC Cancer. 2009 Dec 3;9:421. doi: 10.1186/1471-2407-9-421.

47.

Anti-human papillomavirus therapeutics: facts & future.

Bharti AC, Shukla S, Mahata S, Hedau S, Das BC.

Indian J Med Res. 2009 Sep;130(3):296-310. Review.

PMID:
19901439
48.

Infection of human papillomaviruses in cancers of different human organ sites.

Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC.

Indian J Med Res. 2009 Sep;130(3):222-33. Review.

PMID:
19901431
49.

Human papillomavirus & cervical cancer: looking ahead.

Das BC, Bharti AC, Bharadwaj M.

Indian J Med Res. 2009 Sep;130(3):210-1. No abstract available.

PMID:
19901428
50.

Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection.

Hussain S, Bharti AC, Salam I, Bhat MA, Mir MM, Hedau S, Siddiqi MA, Basir SF, Das BC.

BMC Cancer. 2009 Sep 16;9:329. doi: 10.1186/1471-2407-9-329.

Supplemental Content

Loading ...
Support Center